Sono-Tek Corporation (SOTK)
NASDAQ (CM) NASDAQ (CM) Primary 
Sono-Tek Corporation: Backlog Additions To Support Year-Out Sales
Sono-Tek is seeing strong growth in medical applications, and a solid sales outlook of modest growth or flat sales for the rest of the FY. Customer concentration remains high at SOTK, with 52% of sales from two customers. In general, products need to get validated for momentum to continue. On the other hand, the success in higher ASP sales and in the sorts of things sold in the medical vertical could lend itself to follow-on sales.
Sono-Tek Corporation (SOTK) Q2 2027 Earnings Call Transcript
Sono-Tek Corporation ( SOTK ) Q2 2027 Earnings Call October 14, 2026 10:30 AM EDT Company Participants Christopher Coccio - Executive Chairman R. Harshbarger - President, CEO & Director Stephen Bagley - Chief Financial Officer Conference Call Participants Kirin Smith - ProActive Capital Group, LLC Bill Nicklin Richard Ryan - Oak Ridge Financial Services Group Inc., Research Division Edward Jackson - Northland Capital Markets, Research Division Sam Dufault - Oak Ridge Financial Services Group Inc., Research Division Gregory Weaver - Invicta Capital Management, LLC Jason Ursaner - Bumbershoot Holdings Corp. Presentation Operator Good day, everyone, and welcome to the Sono-Tek Corporation Fiscal Year 2027 Midyear Results Conference Call.
Sono-Tek Q2 Earnings Call Highlights
Sono-Tek NASDAQ: SOTK reported fiscal 2027 first-half revenue growth, wider gross margins and higher profitability, led by a sharp increase in medical-market sales and demand for higher-value production systems. Management also highlighted recent order activity that it said provides increased visibility into fiscal 2028.
Sono-Tek Corporation (SOTK) Misses Q2 Earnings and Revenue Estimates
Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.03 per share a year ago.
SonoTek (SOTK) Moves 18.5% Higher: Will This Strength Last?
SonoTek (SOTK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Sono-Tek Receives Record Order of Over $3.6 Million for a Single Integrated Production Line
Largest Single Production Line Order in Company History Will Support High-Volume Medical Diagnostic Manufacturing MILTON, N.Y., Aug.
Sono-Tek Corporation (SOTK) Q1 Earnings Meet Estimates
Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.05 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.03 per share a year ago.
SonoTek (SOTK) Surges 14.6%: Is This an Indication of Further Gains?
SonoTek (SOTK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Sono-Tek Corporation (SOTK) Q4 2026 Earnings Call Transcript
Sono-Tek Corporation (SOTK) Q4 2026 Earnings Call Transcript
Sono-Tek Q4 Earnings Call Highlights
Sono-Tek NASDAQ: SOTK reported higher profitability and modest revenue growth for fiscal 2026, as management said the company's shift toward larger, higher-value production systems continued to support margins and earnings.
Sono-Tek Corporation (SOTK) Q4 Earnings and Revenues Beat Estimates
Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago.
Sono-Tek Announces $820K Order for Diagnostic Medical Device Coating Systems
Follows Previously Purchased Sono-Tek Systems as Customer Scales Up from Early Production MILTON, N.Y.
